A rapidly adaptable biomaterial vaccine for SARS-CoV-2
F. Langellotto, B. T. Seiler, J. Yu, M. J. Cartwright, D. White, C. Yeager, M. Super, E. J. Doherty, D. H. Barouch, D. J. Mooney
This study develops a biomaterial vaccine using mesoporous silica rods to deliver SARS-CoV-2 antigens and adjuvants, showing rapid antibody responses and neutralizing activity.
bioRxiv · Jul 7, 2020 · PreprintImmunology